Cite
Definitive chemoradiotherapy has comparable survival outcomes to esophagectomy in patients with clinical T1N0M0 esophageal squamous cell carcinoma: real-world data
MLA
Kentaro Sawada, et al. “Definitive Chemoradiotherapy Has Comparable Survival Outcomes to Esophagectomy in Patients with Clinical T1N0M0 Esophageal Squamous Cell Carcinoma: Real-World Data.” International Journal of Clinical Oncology, vol. 27, no. 8, Dec. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....63fce9a733df881990657af66770f7ff&authtype=sso&custid=ns315887.
APA
Kentaro Sawada, Daisuke Kotani, Hiroki Yukami, Saori Mishima, Hisashi Fujiwara, Tomohiro Kadota, Keiichiro Nakajo, Yusuke Yoda, Masaki Nakamura, Hidehiro Hojo, Tomonori Yano, Takeo Fujita, & Takashi Kojima. (2021). Definitive chemoradiotherapy has comparable survival outcomes to esophagectomy in patients with clinical T1N0M0 esophageal squamous cell carcinoma: real-world data. International Journal of Clinical Oncology, 27(8).
Chicago
Kentaro Sawada, Daisuke Kotani, Hiroki Yukami, Saori Mishima, Hisashi Fujiwara, Tomohiro Kadota, Keiichiro Nakajo, et al. 2021. “Definitive Chemoradiotherapy Has Comparable Survival Outcomes to Esophagectomy in Patients with Clinical T1N0M0 Esophageal Squamous Cell Carcinoma: Real-World Data.” International Journal of Clinical Oncology 27 (8). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....63fce9a733df881990657af66770f7ff&authtype=sso&custid=ns315887.